GB

Gregory Brown

CurveBeam AI Limited | Chief Executive Officer, Managing Director
Mr Brown has 35 years experience in the healthcare industry, in medical devices (including in vitro diagnostic medical devices) and personalised medicine. Prior to joining CurveBeam, Mr Brown held marketing roles at Baxter Diagnostics (Australia and United Kingdom), Roche Molecular Systems Inc. (Switzerland and U.S.) and Digene Corporation (U.S. and Germany) and was Chief Executive Officer at ImpediMed Limited (ASX:IPD). Until April 2023, Mr Brown was a director of Australian biotechnology company Immunexpress Pty Ltd. He is also a director of an Australian management consulting company, Cintra Consulting Pty Ltd. He has previously served as a director of Trinity Biotech plc (Nasdaq: TRIB), ImpediMed Limited (ASX:IPD), Minomic International Limited and the University of Queenslands commercialisation company, UniQuest Pty Ltd.

Company and Roles

Company
Title
Tenure
Since
CVB
CurveBeam AI Limited
  • Chief Executive Officer
  • Managing Director
9yrs, 6mthOct 2014

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CVB
CurveBeam AI Limited
28/09/2318,869,624N/A4,739,940N/A